SecBot SecBot
EFFECT ·Filed Jul 20, 2026

DCOY

Decoy Therapeutics Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago SEC9999999995-26-002352
IPO/offering going effective
Actionable Insight • Neutral

Monitor for a prospectus or pricing announcement to determine the offering size and terms. The company may now proceed with an offering, which could pressure the stock price due to dilution. Given the small market cap, even a modest offering could have significant impact.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
DCOY ▼ -76.63% at T+60d
NEUTRAL call -76.63% · α vs SPY -81.47% · entry $5.31 → $1.24
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
-7.26%
call -7.26% · α -8.09%
$4.92
settled 3mo ago
T+5d
-29.50%
call -29.50% · α -29.10%
$3.74
settled 3mo ago
T+20d
-33.65%
call -33.65% · α -37.77%
$3.52
settled 2mo ago
T+60d
-76.63%
call -76.63% · α -81.47%
$1.24
settled 14d ago

Price Chart

Loading chart...

Executive Summary

The SEC declared effective a registration statement (File No. 333-297381) for Decoy Therapeutics Inc. as of July 17, 2026. This allows the micro-cap biopharmaceutical company to offer and sell securities, potentially leading to dilution. The exact nature of the offering (IPO, follow-on, or shelf) is not specified in the filing.

Key Facts

  • Effectiveness date: July 17, 2026
  • SEC File No.: 333-297381 under the Securities Act of 1933
  • Company: Decoy Therapeutics Inc., a pharmaceutical preparations company with $3M market cap
  • Former names: Salarius Pharmaceuticals, Inc. and Flex Pharma, Inc.

Financial Impact

Registration effective but no offering size disclosed; potential dilution for existing shareholders if shares are sold

dilution

Risk Factors

  • Potential dilution if shares are issued
  • Lack of transparency on offering details increases uncertainty

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002352
Document: 9999999995-26-002352-index.html9999999995-26-002352
Document: 9999999995-26-002352.txt9999999995-26-002352
11 reports for DCOY
Performance horizon
100% Hit rate @ T+5 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +67.67%Jun 29, 2026
Filters
Rows
Reports for DCOY — sortable, filterable
TypeNow
Oct 19, 2026
8d ago
EFFECT
NEUTRAL ★ 4/10
$1.17 $0.9100▼ −22.22%▼ −22.08%$1.03 (−11.97%)
Oct 7, 2026
19d ago
S-1
BEARISH ★ 6/10
$1.52 $1.23▲ +19.08%▲ +18.80%$1.03 (+32.24%)
Sep 23, 2026
4w ago
8-K
BEARISH ★ 6/10
$3.11 $1.86▲ +40.35%▲ +39.94%$1.03 (+66.88%)
Aug 4, 2026
11w ago
DEFA14A
NEUTRAL ★ 3/10
$4.19 $3.60▼ −14.08%▼ −14.43%$1.03 (−75.42%)
Jul 20, 2026
14w ago
EFFECT
NEUTRAL ★ 4/10
$5.31 $3.74▼ −29.50%▼ −29.10%$1.03 (−80.58%)
Jun 29, 2026
17w ago
8-K
BEARISH ★ 7/10
$9.59 $7.25▲ +24.40%▲ +25.79%$1.03 (+89.26%)
Jun 25, 2026
17w ago
EFFECT
NEUTRAL ★ 5/10
$5.92 $7.62▲ +28.76%▲ +27.20%$1.03 (−82.60%)
Jun 4, 2026
20w ago
DEFA14A
NEUTRAL ★ 3/10
$6.71 $5.90▼ −12.07%▼ −9.52%$1.03 (−84.65%)
Apr 30, 2026
25w ago
10-K/A
NEUTRAL ★ 2/10
$6.05 $6.01▼ −0.66%▼ −2.39%$1.03 (−82.98%)
Apr 2, 2026
29w ago
8-K
MIXED ★ 6/10
$5.80 $5.84▲ +0.69%▼ −2.93%$1.03 (−82.24%)
Showing 10 of 11

US Market Status

Market Open — Closes in 1h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026